
Join to View Full Profile
S Hawthorne RdWinston Salem, NC 27157
Phone+1 336-716-2255
Dr. Bleyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anthony Bleyer is Professor of Internal Medicine/Nephrology at Wake Forest School of Medicine, Winston-Salem, NC. Dr. Bleyer is originally from Rhode Island. He attended Baylor College of Medicine, Houston, Texas and completed an internal medicine residency at Johns Hopkins Hospital, Baltimore, Maryland and a fellowship in nephrology at the University of Pennsylvania, Philadelphia, Pennsylvania. He then joined the faculty of Wake Forest School of Medicine in Winston-Salem, North Carolina, where he has been for over 30 years. Dr. Bleyer leads the Rare Inherited Kidney Disease Team at Wake Forest and is a clinical researcher who has helped to identify mutations in UMOD, MUC1, REN, and APOA4 as causes of inherited kidney disease, resulting in a newgenetic diagnosis for over 500 families with these conditions. The mission statement of his team is “To help one patient, one family at a time.”
Education & Training
- University of Pennsylvania Health SystemFellowship, Nephrology, 1990 - 1992
- Johns Hopkins UniversityResidency, Internal Medicine, 1987 - 1990
- Baylor College of MedicineClass of 1987
Certifications & Licensure
- NC State Medical License 1992 - 2026
- PA State Medical License 1991 - 1992
- TX State Medical License 1988 - 1992
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
- Fellow (ASNF) American Society of Nephrology
Clinical Trials
- Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels Start of enrollment: 2019 Mar 12
Publications & Presentations
PubMed
- Implementation of a Kidney Genetic Service Into the Diagnostic Pathway for Patients With Chronic Kidney Disease in Canada.Clara Schott, Monica Arnaldi, Cadence Baker, Jian Wang, Adam D McIntyre
Kidney International Reports. 2025-02-01 - Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors.Silvana Bazua-Valenti, Matthew R Brown, Jason Zavras, Magdalena Riedl Khursigara, Elizabeth Grinkevich
The Journal of Clinical Investigation. 2024-12-16 - 1 citationsDescription of a New Simple and Cost-Effective Molecular Testing That Could SimplifyVariant Detection.Victor Fages, Florentin Bourre, Romain Larrue, Andrea Wenzel, Jean-Baptiste Gibier
Kidney International Reports. 2024-05-01
Lectures
- Autosomal Dominant Tubulointerstitial Kidney DiseaseAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019
Other
- 3D Computed Tomography Angiography as a Novel Post-Processing Approach in Diagnosis of Pediatric Malignant Bone TumorsAnthony Bleyer, MD, Journal of Pediatric Rehabilitation Medicine
https://www.doximity.com/articles/a54c53b8-d1c9-4467-85f0-1781fe53fe2d
UpToDate, Wolters Kluwer Health - 2012-12-04 - 3D Computed Tomography Angiography as a Novel Post-Processing Approach in Diagnosis of Pediatric Malignant Bone TumorsAnthony Bleyer, MD, Journal of Pediatric Rehabilitation Medicine
https://www.doximity.com/articles/a54c53b8-d1c9-4467-85f0-1781fe53fe2d
UpToDate, Wolters Kluwer Health - 2013-03-21 - 3D Computed Tomography Angiography as a Novel Post-Processing Approach in Diagnosis of Pediatric Malignant Bone TumorsAnthony Bleyer, MD, Journal of Pediatric Rehabilitation Medicine
https://www.doximity.com/articles/a54c53b8-d1c9-4467-85f0-1781fe53fe2d
UpToDate, Wolters Kluwer Health - 2012-02-16 - Join now to see all
Press Mentions
- Natera to Present New Renasight Data at ASN Kidney Week 2024October 22nd, 2024
- Wake Forest University School of Medicine Kidney Disease Efforts Highlighted in FDA Award to Critical Path InstituteSeptember 30th, 2024
- Hemodialysis Timing May Affect Post-Surgery Death RiskNovember 30th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: